[101 Pages Report] The cell harvesting market was valued at USD 196.9 Million in 2017 and expected to grow at a CAGR of 8.7% during the forecast period to reach USD 324.5 Million in 2023. Factors such as rising investments in regenerative medicine and cell-based research, growth of the biotechnology and biopharmaceutical industry, and increasing incidence of chronic and infectious diseases are contributing to the growth of this market.

Years considered in this report:

2017  Base Year2018  Estimated Year2023  Projected Year

The objectives of this study are as follows:

To define, describe, and forecast the market for cell harvesting, on the basis of type, application, end user, and region

To provide detailed information regarding the major factors influencing growth of the market (drivers, opportunities, and restrains)

To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders

To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)

To profile key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies

To track and analyze competitive developments such as product launches, expansions, acquisitions, and collaborations in the market for cell harvesting

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the cell harvesting market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation by type, application, end user, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources referred to for this research study include publications from government sources such as the International Society for Stem Cell Research, World Health Organization, National Institutes of Health, American Society for Cell Biology, International Cell Research Organization; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements have been used to identify and collect information useful for this extensive commercial study of this market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The breakdown of profiles of primaries is shown in the figure below:

Value Addition for the Buyer:

This report aims to provide insights into the global market for cell harvesting. It provides valuable information on cell harvesting type, application, and end user. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to understand the strategies undertaken by them to be competitive in this market.

Scope of the Report:

This report categorizes the cell harvesting market into the following segments:

By Type

Manual Cell Harvesters

Automated Cell Harvesters

By Application

Biopharmaceutical Application

Stem Cell Research

Other Applications

By End User

Biotechnology & Biopharmaceutical Companies

Research Institutes

Other End Users

By Region

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe (RoE)

Asia Pacific

China

Japan

India

Rest of Asia-Pacific (RoAPAC)

Rest of the World (RoW)

Customization Options:

Cell harvesting is the process of harvesting cells from the culture media during upstream and downstream bioprocessing. Cell harvesters are used extensively for the cell harvesting process and are compatible with a wide range of assays. The global market for cell harvesting is expected to reach USD 324.5 Million by 2023 from USD 213.8 Million in 2018, at a CAGR of 8.7%. Rising investments in regenerative medicine and cell-based research, growth of the biopharmaceutical and biotechnology industry, and increasing incidence of chronic and infectious diseases are the major driving factors for this market.

The cell harvesting market is segmented on the basis of type, application, and end user. The market based on application is segmented into research institutes, biotechnology & biopharmaceutical companies, and other end users. The biotechnology & biopharmaceutical companies segment is expected to account for the largest share of the market in 2018. The growth in this segment is primarily attributed to high prevalence of chronic diseases worldwide and the increasing R&D activities to develop new products across the globe.

Based on type, the market for cell harvesting is segmented into manual and automated cell harvesters. The manual cell harvesters segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to their ease of use and low price as compared to automated harvesters.

By region, the cell harvesting market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe; however, the APAC region is expected to witness the highest growth rate during the forecast period. Increasing private and government funding for stem cell research in this region and growing expansion of key market players in emerging Asian countries are some of the factors driving the APAC market.

The growing use of single-use bioprocessing containers is expected to hinder the growth of this market in the coming years.